July 16, 2021 -- LabGenius has announced a research collaboration with Ablynx, a Sanofi company, for therapeutic proteins.
The company develops machine learning for protein engineering via its machine learning-driven evolution engine (EVA platform) and will combine its expertise with Ablynx's existing therapeutic Nanobody protein technology, it said. The optimized candidates will then be advanced by Ablynx into further validation studies.
Financial terms of the partnership were not disclosed.